Breakfast Alert -Mountfield Group, Be Heard, Warehouse REIT, Real Good Food and more...


Small Cap Brunch       

Set menu


Total number of AIM Companies (Incl Susp):


Total number of AIM Companies trading:


*as at close of business 21 March 2018


Standard List**  of Main Market:

Total number of Standard List Companies

(Incl Susp):


Total number of Standard List Companies trading:


*as at close of business 21March 2018


NEX Growth Market:

Total number of NEX Growth Market Companies (Incl Susp):


Total number of NEX Growth Market Companies trading:


*as at close of business 22 March 2018

                                *A corporate client of Hybridan LLP

**  Standard Listing as defined by Hybridan LLP to be a business with strictly operational activity


Dish of the day

No Joiners Today

Off the menu   

No Leavers Today


What’s cooking in the IPO kitchen?

NEX Exchange

Sativa Investments Due 29 Mar. Raising £1m at 1p. Mkt cap £4m.  Investment Vehicle  for investment opportunities and acquisitions in companies which are well-placed to take advantage of the dynamic regulatory environment surrounding legal Medicinal Cannabis.


Kore Potash— advanced stage mineral exploration and development company whose primary asset is its interest in the Sintoukola Project, a potash project located in the Republic of Congo. ) Measured, Indicated and Inferred Mineral Resource of 5,953Mt at an average grade of 22.0% KCl. Offer raising $13.14m with market cap of £56.4m. Due 29 March.

Perfomatrix PLC, a global end to end Performance Marketing technology and services company headquartered in the UK, is looking to join AIM in early April 2018, offer TBC

Crusader Resources, an ASX-listed public company incorporated in Australia, which is primarily focused on the exploration and development of gold assets in Brazil. Offer TBC, expected late March.

SimplyBiz, a Financial Services Firm, looking to join AIM raising £30m via placing and £34.6m via a sale of existing ordinary shares at 170p giving a market cap of £130m. Expected 4 April

Polarean  - Medical drug-device combination company operating in the high resolution medical imaging market. Offer raising £3m at 15p with market cap of £11.01m. Due 29 March


Main Market Premium Listing

Gore Street Energy Storage Fund—Seeking to raise £100m for the purposes of investment in a diversified portfolio of utility scale energy storage projects.  Due 12 April.                            


Brunch buffet

Mountfield Group (LON:MOGP) 1.45p £3.5m

The Directors of Group  announced that 2017 saw a sizeable increase in Group's turnover and they expect, following conclusion of the audit, to announce a substantial increase to net profit achieved in the year to 31 Dec 2016.

Both CAF and MBG have performed very well during 2017, having both won a number of large contracts in the second half of the year.

As announced on 27 Nov 2017, the Group has a strong order book for 2018 and has, since then, announced further contracts for MBG. Currently the Group's orders secured for 2018 stand at £8.8m, a record high for the Group at this point of the year.  Of this amount, CAF's figure is £6.5m and MBG's secured orders are £2.3m.

Whilst CAF continues principally with its two substantial contracts for flooring at new City HQ office buildings it is also planning and negotiating other contract works for offices and data centres in London and also overseas. 

MBG's workload continues to expand with further contracts including that won from its leading UK telecoms provider client and from a resurgence of specialist data centre construction work. It is currently in advanced negotiations on two contracts that have an aggregate value of £2.3m.

The Directors are therefore optimistic as to the Group's outlook and anticipate that the Group's performance will continue to improve in 2018. 


1pm (LON:OPM) 48p £40.04m

1pm, the independent specialist provider of finance facilities to the SME sector announced that it has signed an asset finance facility with the British Business Bank ("BBB") under BBB's ENABLE Funding programme that will provide £35m of additional funding. The Facility will enable the Group to significantly expand its asset finance lending to businesses across the UK SME sector, primarily for those seeking "hard asset" finance. The new facility increases the total funding facilities available to the Group to in excess of £155m.

The Group continues to experience strong demand for asset finance including 'hard assets' the funding for which is provided through its Bradgate subsidiary. The deployment of this Facility will enable Bradgate to increase the amount and diversify the range of lending for business-critical equipment used by SME businesses while resolutely maintaining its strict underwriting criteria.

Deploying funds over the life of the Facility will enable the Group to significantly reduce its blended borrowing cost thus delivering one of management's key operational objectives to increase the Net Interest Margin from the Group's lending activities.


Shield Therapeutics (LON:STX) 17.5p £20.37m

Shield Therapeutics PLC, a commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients' unmet medical needs, announced that the European Commission (EC) has adopted the Decision to extend the approved indication for Feraccru to include treatment of all adults with iron deficiency (ID) with or without anaemia.

This decision, which follows the recent positive opinion of the Committee for Human Medicinal Products  (CHMP) of the European Medicines Agency (EMA) to adopt this extension of Feraccru's marketing authorisation approval, will provide Feraccru with a much broader commercial opportunity, as previously it was only approved and marketed in Europe for the treatment of iron deficiency anemia (IDA) in adult patients with inflammatory bowel disease (IBD).

"We are extremely pleased that following the CHMP positive opinion in February, the EU Commission has so rapidly ratified the expansion of the indication for Feraccru.  This decision confirms a significantly broader patient population target opportunity for Feraccru in Europe, where 40 million people are estimated to be iron deficient."


Be Heard (LON:BHRD) 2.28p £21.85m

Be Heard, the digital marketing services group, announced the appointment of Simon Pyper as CFO with effect from 9 Apr 2018.

Simon has broad experience in the media sector and consumer industries, from senior leadership roles over the past three decades.  Most recently, he was on the board of GlobalData plc, the AIM-listed data and analysis business, where he served as CEO of the Company from 2007 to 2016 and as CFO from 2016 to 2017.  Under Simon's leadership, GlobalData plc was admitted to AIM in 2010 and grew to a market capitalisation of more than £500m.

Previously Simon was Group FD of Datamonitor plc (2005-2007), a B2B media company which was acquired by Informa plc, and Finance Director of Musgrave UK (2001-5), the Irish grocery wholesaler and franchisor which acquired Budgens plc in 2002 and Londis in 2004.  Before then he held a variety of senior finance and commercial roles at Arcadia Group.

Following Peter Scott's appointment as Group CEO in January, and with Simon Pyper's imminent arrival, the Board has decided that the COO responsibilities will be shared between Peter and Simon, and accordingly Robin Price has decided to step down from the Board with effect from 9th April 2018. 


Warehouse REIT (LON:WHR) 100p £167.6m

Further to the announcement of Feb 5 2018, Warehouse REIT, the AIM-quoted specialist warehouse investor, confirmed that it has completed the acquisition from Hansteen Holdings plc of its Industrial Multi Property Trust portfolio, comprising 51 assets, the majority being multi-let UK urban warehouses, for £116m. As also stated, the acquisition is in line with the Company's strategy and concludes the successful deployment of all funds raised by the Company at IPO in Sept 2017, significantly ahead of plan, and brings the total property acquisitions to date to £279m.


Real Good Food (LON:RGD) 16p £12.5m

Real Good Food announced an update on its funding. The Board has identified that further substantial additional funding will be required over the coming months for working capital and investment purposes in order to implement the Group's business plan. The Board continues to explore the detail of financing this requirement, including the issue of new equity. 

As announced on 31 Jan 2018, the Group's three major shareholders, Napier Brown Ingredients Limited, Omnicane International Investors Limited, and certain funds managed by Downing LLP continue to demonstrate their support for the Group.  They have executed a term sheet, to that end, to provide additional funds to support the Company's working capital requirements, in the form of a draw-down loan note facility of up to £4m in aggregate, with Omnicane and NB Ingredients Ltd each providing up to £1.713m and certain funds of Downing LLP providing £0.574m.  These funds will relieve pressure on cash availability over the coming months whilst longer term funding arrangements are put in place.


ITM Power (LON:ITM) 33p £102.39m

Shell has announced the opening of a new hydrogen refuelling station at Shell Beaconsfield in Buckinghamshire. Supplied by ITM Power, this opening follows the launch of the first fully branded and public hydrogen refuelling site in the UK at Shell Cobham in Febr 2017.

Situated at one of the UK's busiest service stations, Shell Beaconsfield on the M40 will be the first site in the UK to bring hydrogen under the same canopy as petrol and diesel, providing drivers with a range of fuel choices to co-exist with traditional transport fuels. The hydrogen is generated on-site using an electrolyser that requires only water and electricity to generate the hydrogen gas.

Hydrogen fuel cell electric vehicles convert hydrogen into electricity to power the engine and produce only heat and water when driven. They can travel up to 700 kilometres on a single tank and can be refuelled in a few minutes.


Mosman Oil And Gas (LON:MSMN) 0.82p £2.77m

Mosman Oil and Gas Limited the oil exploration, development and production company, announced continued progress in respect to its Arkoma Stacked Pay Project.

The Operator is progressing the agreed and funded work program to install high-volume Electrical Submersible Pumps ("ESPs") and infrastructure upgrades to accommodate the expected increase in production volumes of water. The process of design, purchase, delivery and installation is underway to install ESPs in two wells. The current schedule is to install the two ESPs by the end of May and build production rates to full production by the end of July.

To facilitate the completion of the infrastructure upgrades and an extended period of production the parties have held discussions in respect of the existing Second Option, whereby Mosman can increase its interest by 27 March 2018, being the latest option exercise date. Inland Operating Company Inc. ("Inland") has now agreed to extend the latest option exercise date from 27 March 2018 to 31 July 2018.




Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Minotaur Exploration's Andrew Woskett highlights its technical credentials...

Minotaur Exploration's (ASX:MEP) Andrew Woskett speaks to Proactive's Andrew Scott soon after announcing they're to proceed with the acquisition of the Pyramid Gold project in north Queensland. The project is 180 kilometres south of Townsville, covers 150 square kilometres and includes two main...

49 minutes ago

10 min read